HarperCollins India to publish Albinder Singh Dhindsa’s BUILDIT, a candid account of building Blinkit on 15th April 2026

3 weeks ago

GURGAON, India, April 11, 2026 /PRNewswire/ -- HarperCollins Publishers India is delighted to announce the upcoming publication of Albinder Singh Dhindsa's…

Building an Ecosystem of Thalassemia Care – Manipal Hospital Yelahanka Leads the Way, A Step Towards Stronger, More Compassionate Futures

3 weeks ago

BENGALURU, India, April 11, 2026 /PRNewswire/ -- Some healthcare initiatives treat a condition. Others try to change the way we live…

Ministry of Petroleum & Natural Gas extends bulk LPG allocation to key industrial sectors

3 weeks ago

NEW DELHI, April 10, 2026 /PRNewswire/ -- The Ministry of Petroleum & Natural Gas (MoPNG) has issued an order to…

Adyen Launches Intelligent Money Movement To Unify Enterprise Payments, Liquidity Management And Payouts

3 weeks ago

NEW YORK, April 9, 2026 /PRNewswire/ -- Adyen, the global financial technology platform of choice for leading businesses, today announced Intelligent…

MEXC Lists 135 New Tokens in March, Reports 39% Jump in New Token Traders

3 weeks ago

VICTORIA, Seychelles, April 9, 2026 /PRNewswire/ -- MEXC, the world leader in 0‑fee digital asset trading, has published its March 2026…

MoPNG expands supply of 5 kg LPG cylinders, strengthening access to migrants

3 weeks ago

NEW DELHI, April 10, 2026 /PRNewswire/ -- The Ministry of Petroleum & Natural Gas (MoPNG) has significantly enhanced the availability…

IVY Rx Claims Evaluated: 2026 Compounded GLP-1 Telehealth Program Details, Monthly Pricing Structure, Clinician Access Model, and Patient Eligibility Information

3 weeks ago

Miami, FL, April 10, 2026 (GLOBE NEWSWIRE) -- Affiliate Disclosure: This article contains affiliate links. If readers purchase through these…

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

3 weeks ago

Cheyenne, WY, April 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute…

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

3 weeks ago

April 10, 2026 17:02 ET  | Source: Replimune, Inc. WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…

No More Fuel Anxiety! AION UT Debuts in Australia, Setting a New Benchmark for Urban Electric Vehicles

3 weeks ago

MELBOURNE, Australia, April 10, 2026 /PRNewswire/ -- On April 10, the highly anticipated 2026 Melbourne Motor Show grandly kicked off.…